Luciano J. Costa, MD, PhD; Paul Shaughnessy, MD

Optimizing ASCT in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma Through Stem Cell Mobilization Techniques

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Community Practice Connections™: Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

CAR T-Cell Therapy in Multiple Myeloma: Key Considerations for Patient Selection, Transplant, and Applying Recent Data

Anita Afzali, MD, MPH, MHCM; Marla C. Dubinsky, MD; Christina Ha, MD, FACG, AGAF

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Jane S. Davis, CRNP, DNP; Jean Colaneri, ACNP-BC, CNN-NP

Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD

Burst CME: Improving Outcomes for Your Patient with Vitiligo

Elizabeth Verna, MD, MSc; Arun B. Jesudian, MD

Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Steven Nathan, MD; Kristin Highland, MD, MSCR

Community Practice Connections™: Improving Prognosis in SSc-ILD: Best Practices in Diagnosis, Optimizing Clinical Management, and Efficient Patient Communication

Rodolfo Bordoni, MD; Hossein Borghaei, DO, MS

EGFR Exon 20 NSCLC Tumor Board Aligning Patient and Evidence to Inform Treatment Decisions in Real World Care Scenarios

Hetty Carraway, MD, MBA, FACP; Gail J. Roboz, MD

Virtual AML Coffee Talk: Challenging the Experts on How They Treat and Individualize Care With Novel Therapies

Josie Montegaard, NP; Jennifer Brown, MD, PhD; Christina Russomanno, RN, MSN, NP-C; Nicole Lamanna, MD

Community Practice Connections™: Show Me Your Care Plan!™ Nursing Strategies to Individualize CLL Patient Care in the Context of Recent Evidence

The Gut Microbiome and Immunotherapy

Douglas W. Blayney, MD; Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP; Jyoti Malhotra, MD, MPH; Beth Sandy, MSN, CRNP

Live Tumor Board! Experts Navigate the Impact of Neutropenia Across Tumor Types

Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Elizabeth Verna, MD, MSc; Lisa B. VanWagner, MD, MSc, FAST, FAHA

Advances In™ Cirrhosis: Reframing the Management of Hepatorenal Syndrome-Acute Kidney Injury: A Review of Current Strategies

Burst Expert Illustrations & Commentaries™: Current Treatments for Esophageal Variceal Hemorrhage

Matthew Lunning, DO, FACP; Yi Lin, MD, PhD

Community Practice Connections™: Translating Recent Evidence on CAR T-Cell Therapy to the Real-World Management of Lymphoid Malignancies

Corey S. Cutler, MD, MPH; Catherine Lee, MD

Expert Illustrations & Commentaries™: Exploring the Rationale for Emerging Mechanistic Approaches in cGvHD

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Fátima Cardoso, MD; Mario Campone, MD, PhD; Giuseppe Viale, MD, FRCPath

Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP

Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Ruben A. Mesa, MD, FACP; Jamile M. Shammo, MD, FASCP, FACP; Naveen Pemmaraju, MD

Placing New MPN Therapies in Context Through Illustrated Case Discussions

Narjust Duma, MD; Emeline M. Aviki, MD, MBA, FACOG; Gilberto de Lima Lopes, MD, MBA, FASCO; Ana Maria López, MD, MPH, MACP, FRCP; Estelamari Rodriguez, MD, MPH 

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Robert Dreicer, MD, MS, MACP, FASCO; Tomasz Beer, MD, FACP; Scott Tagawa, MD, MS, FACP; Tanya Dorff, MD

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Medical Crossfire: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Naval G. Daver, MD; Guillermo Garcia-Manero, MD; Uma Borate, MD, MS; Jacqueline S. Garcia, MD

Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Aditya Bardia, MD, MPH; Erika P. Hamilton, MD; Komal Jhaveri, MD, FACP; Nicholas Turner, MD, PhD 

Medical Crossfire®: Evaluating the Potential Role of Next-Generation Selective Estrogen Receptor Degraders in the ER+/HER2- Breast Cancer Treatment Paradigm

Christopher R. Flowers, MD, MS, FASCO; Frederick L. Locke, MD; Kami J. Maddocks, MD; Laurie H. Sehn MD, MPH

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients with Relapsed/Refractory DLBCL

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Edward B. Garon, MD, MS; Lyudmila Bazhenova, MD; Solange Peters, MD, PhD; Zofia Piotrowska, MD, MHS

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Community Practice Connections™: Optimally and Safely Integrating Novel Therapies Across the DLBCL Care Spectrum

Michael A. Choti, MD; John L. Marshall, MD; Christopher Lieu, MD; Manish A. Shah, MD

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

Leonard G. Gomella, MD, FACS; Primo N. Lara Jr, MD; Daniel P. Petrylak, MD

Community Practice Connections™: 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Charles Vega, MD, FAAFP; Sandeep Nathan, MD, MS; Maja Zaric, MD

Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care.

Show Me Your Care Plan! Nursing Strategies to Support Continuity of Care in the Treatment of Multiple Sclerosis

Sundar Jagannath, MD, FASCO; Nikhil Munshi, MD

Oncology Consultations™: Coordinating Care for Patients with Multiple Myeloma Between CAR T Centers of Excellence and the Oncology Community

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Terry P. Mamounas, MD, MPH, FACS; Sara M. Tolaney, MD, MPH

Community Practice Connections™: Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Casey O’Connell, MD; Kristin Horwood, ACNP-BC, AOCNP

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns While Managing Low-to-Intermediate Risk MDS

Marc R. Bloomenstein OD, FAAO; Mile Brujic OD, FAAO

Community Practice Connections™: Utilizing Topical Treatments in Presbyopia—How Will the Paradigm Shift With an Updated Armamentarium?

Patrick I. Borgen, MD; Sara A. Hurvitz, MD, FACP; Hope S. Rugo, MD, FASCO; Debu Tripathy, MD

39th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™

Joyce O’Shaughnessy, MD; Sunil S. Badve, MD, FRCPath; Judy C. Boughey, MD; Yuan Yuan, MD, PhD

Community Practice Connections™: Testing and Utilization of Ki-67 and Other Prognostic Markers for Clinical Decision-Making in HR-Positive, HER2-Negative Breast Cancer

Charu Aggarwal, MD, MPH; Alexander Drilon, MD; Lynette M. Sholl, MD

Medical Crossfire®: Implications of Tumor Testing Results Across Advanced NSCLC Treatment

Daniel P. Petrylak, MD; Gert Attard, MD; Celestia (Tia) S. Higano, MD, FACP; Tian Zhang, MD, MHS

Cases and Conversations™: How The Experts Make Evidence-Based Treatment Decisions in Castration-Resistant Prostate Cancer

Diana Jalal, MD; Eugene E. Wright, Jr., MD

Community Practice Connections™: Anemia of Chronic Kidney Disease – Understanding the Disease to Improve Patient Outcomes

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD; MPH, Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Community Practice Connections™: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

Jorge Plutzky, MD; Alison Bailey, MD, FAACVPR, FACC; Nihar R. Desai, MD, MPH; Mary P. McGowan, MD

Community Practice Connections™: Determining When and How to Integrate PCSK9 Inhibition Into Practice

Anjay Rastogi, MD, PhD; Dawn Jacob Laney, MS, CGC, CCRC

Advances In Recognizing and Treating Cardiac and Renal Manifestations in Patients With Fabry Disease

Darin T. Okuda, MD, FAAN, FANA; Le H. Hua, MD, FAAN

Advances In™ Personalizing MS Management Plans: Strategies for Optimizing Long-Term Patient Outcomes in MS and Individualizing Treatment within the S1P Receptor Modulator Class

Expert Insights: Current and Future Perspectives for the Management of Neuroendocrine Neoplasms

Marc R. Bloomenstein OD, FAAO; Justin Schweitzer, OD, FAAO; Walter Whitley, OD, MBA, FAAO

Community Practice Connections™: Exploring Treatments on the Horizon in MGD-Associated Dry Eye Disease

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA; I. Brian Greenwell, MD; Mary Nauffal, PharmD, MS, BCOP; Jennifer K. Elder, RN, MSN, BMTCN

Clinical Conversations with the Cancer Care Team: Optimizing the Care of Patients on CAR T-Cell Therapy Through Multidisciplinary Collaboration and Patient Insights

Angela Fleischman, MD, PhD; Jill Brennan-Cook, DNP, RN-BC, CNE; Natasha Johnson, MSN, APRN, AOCNP; Sandra Kurtin, PhD, ANP-C, AOCN


Cases and Conversations™ With the Oncology Nursing Team: Making Sense of How We Treat MPNs Today and How Novel Strategies Will Shape Patient Care Tomorrow

Joyce O’Shaughnessy, MD; Heather L. McArthur, MD, MPH; Hatem Soliman, MD

Community Practice Connections™: Integrating New Treatment Options into the Management of Triple Negative Breast Cancer

Kelley R. Branch, MD, MSc, FACC, FSCCT; Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC

Expert Illustrations & Commentaries™: Protecting Patients with CAD and PAD from Secondary Events with Effective Antithrombotic Strategies

R. Sharon Chinthrajah, MD; Carla M. Davis, MD; and Edwin H. Kim, MD, MS

The Future of Food Allergy: Novel Treatment Options on the Horizon

Jared Weiss, MD; Michael Pulley, MD, PhD; Beth Sandy, MSN, CRNP

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

Jenny McDade Despotovic, DO; Laura Dogan, RN, BSN, CPN; Caroline Piatek, MD; Jennifer Russell, A-G NP

Medical Crossfire®: What Role Does the Onco-Nurse Play in the Care and Management of Patients With ITP?

Esen K. Akpek, MD; John D. Sheppard, MD, MMSc, FACS

Advances in™ Sjögren Syndrome-Related Dry Eye Disease: A Focus on Pathophysiology and Clinical Trials

Manesh R. Patel, MD; Marc P. Bonaca, MD, MPH, FAHA, FACC; Jorge Antonio Gutierrez, MD; Amy W. Pollak, MD, MSc, FAHA

Expert Illustrations & Commentaries Live!™: Antithrombotic Approaches to Reduce the Risk of Secondary Events in CAD and PAD

Hossein Borghaei, DO, MS; Lyudmila Bazhenova, MD; Ferdinandos Skoulidis, MD, PhD

Expanding Innovation in NSCLC Through Biomarker Testing and Efforts to Target KRAS G12C

Andre H. Goy, MD; Noopur Raje, MD; Bijal Shah, MD, MS

Community Practice Connections™: CAR T Preconference Workshop

Nikolai A. Podoltsev, MD, PhD; John Mascarenhas, MD

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

Debu Tripathy, MD; Aditya Bardia, MD, MPH; Claudine Isaacs, MD; Tiffany A. Traina, MD

Community Practice Connections ™: Aligning the Data With Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Vallerie V. Mclaughlin, MD; Richard N. Channick, MD

Expert Illustrations & Commentaries™: Finding the Best Path Forward in PAH Management – A Focus on NO-cGMP Signaling

Amy E. DeZern, MD, MHS; Catherine Broome, MD;  Michele P. Lambert, MD, MTR

Community Practice Connections™: Hematology Workshop: Navigating Nonmalignant Diseases in Everyday Practice 

Jorge E. Cortes, MD; Christopher R. Flowers, MD, MS, FASCO; Lori A. Leslie, MD; Sagar Lonial, MD, FACP

Community Practice Connections™: 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma 

Alan Menter, MD; Abby Van Voorhees, MD; Alice Bendix Gottlieb MD, PhD; Mark Lebwohl, MD; Marcus Zaayman, MD

Virtual Case Studies in Pustular Psoriasis: Refining Our Approaches to the Assessment of Our Patients

Burst Expert Illustrations & Commentaries™: A Clear Focus on Novel Formulations for the Management of Dry Eye Disease

Emerging Therapies for Relapsed/Refractory Multiple Myeloma

Oncology On-Call®: The Experts’ Take on How Sea Changes in GvHD Prophylaxis and Management Can Be Practically Implemented in Your Clinic

Oncology On-Call®: Advancing Care in SCLC with Novel Therapies

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Omid Hamid, MD; Jeffrey S. Weber, MD, PhD; Rodabe N. Amaria, MD; Ragini Kudchadkar, MD; Sapna Patel, MD

Community Practice Connections™: 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Clinical Consultations™: Evolving Paradigms for the Management of Chronic Kidney Disease and Cardiovascular Comorbidities

Cancer Summaries and Commentaries: Report from Atlanta on Advancements in the Treatment of ITP

Maria Dimou, MD, PhD; Matthew S. Davids, MD, MMSc; Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD; Joshua Richter, MD

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

Aditya Bardia, MD, MPH; Joyce O’Shaughnessy, MD; Mothaffar F. Rimawi, MD

Medical Crossfire®: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Bradley J. Monk, MD, FACS, FACOG; Robert L. Coleman, MD, FACOG, FACS; Domenica Lorusso, MD, PhD; Ursula A. Matulonis, MD

Medical Crossfire®: How Are We Integrating Immune Checkpoint Inhibitors and Targeted Therapies to Personalize Therapy in Endometrial Cancer?

Philippe Armand, MD, PhD; Sarah C. Rutherford, MD; Tycel J. Phillips, MD

Medical Crossfire®: Unpacking the Latest in Diagnostics and Decision Drivers for Follicular Lymphoma

Nicolas Palaskas, MD, FACC; Daniel Addison, MD; Eric H. Yang, MD, FACC, FASE; Lili Zhang, MD, FACC

Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Karen M. Winkfield, MD, PhD; Otis Brawley, MD; Ana Maria Lopez, MD, MPH, MACP, FRCP; Jamil Rivers

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

Aditya Bardia, MD, MPH, Adriana D. Corben, MD, Hope S. Rugo, MD, FASCO, Joseph A. Sparano, MD, FACP

Next Generation Sequencing Workshop™: Breast Cancer Edition

Victor M. Rivera, MD, FAAN; Robert K. Shin, MD; Mitzi Joi Williams, MD

Community Practice Connections™: Bridging the Gap in Multiple Sclerosis—A Focus on Clinical and Health Care Disparities in Racial-Ethnic Patient Populations

Expert Illustrations & Commentaries™: Visualizing New Therapies in Uveitic Macular Edema – Understanding Impact With an Updated Armamentarium

Michael E. Wechsler, MD, MMSc; Wanda Phipatanakul, MD, MS

Alleviating Asthma Burden—Identifying and Managing Poorly Controlled Disease in Pediatric Patients

Julie R. Brahmer, MD, MSc, FASCO; Rogerio C. Lilenbaum, MD; Mark A. Socinski, MD; Everett E. Vokes, MD

Community Practice Connection™ 19th Annual Winter Lung Cancer Conference®

Immunotherapy Biomarkers and New Targets in Head and Neck Cancer

Advances in™: How Are Evolutions in DLBCL Reshaping Sequencing Considerations?

Anthony Mato, MD, MSCE; Lindsey Roeker, MD; Chaitra Ujjani, MD

Conversations and Commentaries™: Translating Evolving Data for the Use of BTK Inhibitors in CLL Into Clinical Practice

Arshad M. Khanani MD, MA; Peter K. Kaiser, MD; Sophie J. Bakri, MD

Medical Crossfire®: The Role of Inflammation in the Treatment of Diabetic Macular Edema – Expert Insights and Case Considerations

Joyce O’Shaughnessy MD; Heather L McArthur MD,  MPH; Hatem Soliman MD


Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Courtney DiNardo, MD, MSCE; Keith W. Pratz, MD

Oncology Consultations®: Utilizing Molecular Testing Technologies to Inform Treatment Decision-Making in Acute Myeloid Leukemia

Patrick I. Borgen, MD; Joshua A. Feinberg, MD; Gary Schwartz, MD

REEL Time:  Improving Recovery Times and Quality of Life With Postoperative Opioid-Sparing Strategies for Patients With Breast Cancer

Burst CME™: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 

William D. Chey, MD, FACG, AGAF, RFF; Bruce E. Sands, MD, MS

3rd Annual Virtual Medical Crossfire® in IBS and IBD

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD, MPH; Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Medical Crossfire®: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

One Size Doesn't Fit All - Tailoring Antiretroviral Treatment

Continuing the Conversation: COVID-19 Vaccine Developments and Pharmacist Considerations

This activity features counseling vignettes that will aid pharmacists with identifying populations with risk factors for RSV infection, review strategies to promote awareness of the severity of RSV, and facilitate patient education regarding the importance of vaccinations.

Risks of Respiratory Syncytial Virus in Older Adults: Emerging Prophylactic Vaccines and Intervention Opportunities for Pharmacists

This activity will explain the burden of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) along with the associated challenges of antimicrobial resistance on health systems and patient outcomes.

The Challenges of Hospital-Acquired and Ventilator-Associated Pneumonia and Recent Advancements in Antibiotic Treatment

Where Are We Now? The Changing Role of Pharmacists in the COVID-19 Treatment Landscape

1.5 Credit / Immunization, Infectious Disease

Preventing Pneumococcal Disease Through Vaccination and the Pharmacist’s Role

1.0 Credit / Immunization, Infectious Disease

The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator

0.75 Credit / Infectious Disease, Respiratory, Rheumatology

Exploring the Results of Interleukin-6- Receptor Antagonists in Hospitalized Patients with Severe COVID-19 Infections

Vaccines to Reduce the Burden of Respiratory Syncytial Virus in Older Adults: Understanding the Importance and the Role of the Pharmacist

1.5 Credit / Respiratory, Infectious Disease

Emerging Vaccines for Preventing and Reducing the Risks Associated with Respiratory Syncytial Virus (RSV) in Older Adults: Meeting an Urgent Need

1 Credit / Christopher Bland; Infectious Disease; COVID-19; Vaccines

Continuing Education

Latest News